Thiotepa

Information about Thiotepa

Thiotepa uses

Thiotepa is used in the treatment of brain tumor, breast cancer, non-small cell lung cancer and ovarian cancer. It is used in combination with other cancer medicine during hematopoietic progenitor cell transplantation (HPCT).

How thiotepa works

Thiotepa is an anti-cancer medication. It works by damaging the genetic material (DNA and RNA) of the cancer cells. This stops their growth and multiplication.

Common side effects of thiotepa

Mucosal inflammation, Anemia (low number of red blood cells), Low blood platelets, Decreased white blood cell count (neutrophils)

Available Medicine for Thiotepa

  • ₹17452
    Natco Pharma Ltd
    1 variant(s)
  • ₹18900
    Therdose Pharma Pvt Ltd
    1 variant(s)
  • ₹18000
    Celon Laboratories Ltd
    1 variant(s)
  • ₹18400 to ₹72000
    MSN Laboratories
    2 variant(s)
  • ₹11200
    Getwell Pharma (I) Pvt Ltd
    1 variant(s)
  • ₹10600
    Emcure Pharmaceuticals Ltd
    1 variant(s)

Expert advice for Thiotepa

  • Thiotepa is given as an intravenous infusion (IV infusion) under the supervisión of a doctor.
  • Do not skip any dose and complete the course as suggested by your doctor.
  • Use an effective method of birth control to avoid pregnancy while taking this medication.
  • Your doctor may get regular blood tests done to monitor your blood cell count, platelet count and liver function.
  • It makes you feel dizzy. Do not drive or operate machinery until you know how it affects you.


Content on this page was last updated on 24 March, 2020, by Dr. Varun Gupta (MD Pharmacology)